Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Most of our patients do not have any issues with their injections and come regularly with no problems
Headache: Occasionally reported, usually mild
In addition to weight loss, the Food and Drug Administration (FDA) has approved Wegovy for reducing the risk of heart problems in adults with cardiovascular disease who either have obesity or are overweight
Renewal Requirement Don't Miss This Most Cigna plans require you to lose at least 5% of your starting body weight to continue coverage after the first authorization period (usually 6-12 months)
Whether the dose-reduction strategy translates as cleanly for someone using the drug for both type 2 diabetes and weight management is a different question
